Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Therapeutic benefits reported for SPP-301 in diabetic nephropathy patients

Nov. 14, 2005

PK profiling of Hematide in clinical and preclinical studies

Nov. 14, 2005

FG-2216 shows promise for anemia of cancer

Nov. 14, 2005

Lentivirus-mediated gene therapy for sickle cell anemia and thalassemia to soon enter clinical trial

Nov. 11, 2005

Recent Ligand patent discloses novel androgen receptor modulators

Nov. 11, 2005

Weight loss seen in phase I study of oleoyl-estrone

Nov. 11, 2005

Novel agents for diabetes reported in recent patent literature

Nov. 10, 2005

Astellas selects targets for diabetes and obesity in Metabolex collaboration

Nov. 10, 2005

Takeda licenses Omacor for Japanese market

Nov. 10, 2005

Hepcidin - a new target to prevent anemia of inflammation

Nov. 9, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
Regeneron’s fianlimab lags in melanoma, does $2.3B deal with Parabilis
BioWorld
Regeneron Pharmaceuticals Inc. stuck with the tradition of releasing bad news on Friday afternoon and good news on Monday morning with a pair of announcements...